In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The closing price of Surgery Partners Inc (NASDAQ: SGRY) was $29.77 for the day, down -1.16% from the previous closing price of $30.12. In other words, the price has decreased by -$1.16 from its previous closing price. On the day, 0.55 million shares were traded. SGRY stock price reached its highest trading level at $30.27 during the session, while it also had its lowest trading level at $29.46.
Ratios:
Our analysis of SGRY’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 17.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 18.54. For the most recent quarter (mrq), Quick Ratio is recorded 1.69 and its Current Ratio is at 1.83. In the meantime, Its Debt-to-Equity ratio is 1.76 whereas as Long-Term Debt/Eq ratio is at 1.69.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Macquarie on June 28, 2024, initiated with a Outperform rating and assigned the stock a target price of $31.
On March 06, 2024, Barclays started tracking the stock assigning a Equal Weight rating and target price of $35.
TD Cowen Upgraded its Market Perform to Outperform on November 14, 2023, whereas the target price for the stock was revised from $39 to $35.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 05 ’24 when Bradley Owens bought 9,241 shares for $30.69 per share.
Bane Harrison R. sold 6,325 shares of SGRY for $196,742 on Sep 04 ’24. The National Group President now owns 48,236 shares after completing the transaction at $31.11 per share. On Sep 04 ’24, another insider, Harrison Bane, who serves as the Officer of the company, bought 6,325 shares for $31.11 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SGRY now has a Market Capitalization of 3784481536 and an Enterprise Value of 8618122240. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.31 while its Price-to-Book (P/B) ratio in mrq is 1.94. Its current Enterprise Value per Revenue stands at 2.983 whereas that against EBITDA is 14.972.
Stock Price History:
Over the past 52 weeks, SGRY has reached a high of $36.92, while it has fallen to a 52-week low of $22.05. The 50-Day Moving Average of the stock is 3.52%, while the 200-Day Moving Average is calculated to be 2.21%.
Shares Statistics:
SGRY traded an average of 1.14M shares per day over the past three months and 714740 shares per day over the past ten days. A total of 126.59M shares are outstanding, with a floating share count of 70.86M. Insiders hold about 44.26% of the company’s shares, while institutions hold 68.84% stake in the company. Shares short for SGRY as of 1723680000 were 11316981 with a Short Ratio of 9.90, compared to 1721001600 on 12266288. Therefore, it implies a Short% of Shares Outstanding of 11316981 and a Short% of Float of 19.590001.
